December 11, 2017
An individualized approach to glucose control for adults with type 2 diabetes in the United States resulted in reduced costs and increased quality of life compared with uniform intensive control approaches, according to data published in Annals of Internal Medicine.
“To date, the clinical implications and economic value of individualizing glycemic goals have not been examined,” Neda Laiteerapong, MD, MS, FACP, assistant professor of general internal medicine in the department of medicine and associate director of the Center for Chronic Disease Research and Policy at the University of Chicago, and colleagues wrote. “It is highly unlikely that diabetes trials will be designed to compare the lifetime effects of individualized vs. uniform intensive glycemic control. Without these analyses, the need for policymakers to prioritize individualized diabetes care is uncertain.”